Simcha Therapeutics: Simcha's revenue changed from $1M in Jan 2022 to $2M in Aug 2022
Simcha’s estimated revenue changed from $1M in Jan 2022 to $2M in Aug 2022 increasing 100.0% in this time period.
Read full article »
Simcha is a Connecticut-based clinical-stage biotechnology company that develops and commercializes engineered cytokine therapeutics for the treatment of cancer.
Read more